Cas:571-22-2 (5R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one manufacturer & supplier

Chemical Name:(5R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one

CAS.NO:571-22-2

Synonyms:5beta,17beta-Hydroxyandrostan-3-one;5beta-Androstan-17beta-ol-3-one;Etiocholan-17beta-ol-3-one;5beta-Dihydrotestosterone;17beta-Hydroxyetiocholan-3-one

Molecular Formula:C₁₉H₃₀O₂

Molecular Weight:290.44000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:413.1ºC at 760 mmHg

Density:1.085g/cm3

Index of Refraction:1.536

PSA:37.30000

Exact Mass:290.22500

LogP:3.95910

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5beta,17beta-Hydroxyandrostan-3-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,17beta-Hydroxyetiocholan-3-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5beta-Androstan-17beta-ol-3-one Use and application,17beta-Hydroxyetiocholan-3-one technical grade,usp/ep/jp grade.

Related News: The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. (5R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one manufacturer Their pharmacological activity plays a direct role in the diagnosis, cure, mitigation, treatment, or prevention of disease. (5R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one supplier Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant. (5R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one vendor The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. (5R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one factory AXON is planning a follow-up trial that will include a better-defined group of Alzheimer’s patients suffering from both amyloid plaques and tau tangles, Novak said.